Entrada Therapeutics (TRDA) Current Taxes (2023 - 2025)
Historic Current Taxes for Entrada Therapeutics (TRDA) over the last 3 years, with Q3 2025 value amounting to $620000.0.
- Entrada Therapeutics' Current Taxes fell 7245.67% to $620000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $620000.0, marking a year-over-year decrease of 7245.67%. This contributed to the annual value of $667000.0 for FY2024, which is 8342.45% down from last year.
- Latest data reveals that Entrada Therapeutics reported Current Taxes of $620000.0 as of Q3 2025, which was down 7245.67% from $802000.0 recorded in Q1 2025.
- Over the past 5 years, Entrada Therapeutics' Current Taxes peaked at $7.4 million during Q2 2023, and registered a low of $620000.0 during Q3 2025.
- Over the past 3 years, Entrada Therapeutics' median Current Taxes value was $3.1 million (recorded in 2023), while the average stood at $3.2 million.
- Its Current Taxes has fluctuated over the past 5 years, first crashed by 4413.64% in 2024, then crashed by 8630.23% in 2025.
- Over the past 3 years, Entrada Therapeutics' Current Taxes (Quarter) stood at $4.0 million in 2023, then crashed by 83.42% to $667000.0 in 2024, then dropped by 7.05% to $620000.0 in 2025.
- Its Current Taxes was $620000.0 in Q3 2025, compared to $802000.0 in Q1 2025 and $667000.0 in Q4 2024.